Zhejiang Chint Electrics Co.Ltd(601877) it is proposed to sell the equity of some industrial and commercial distributed photovoltaic power station project companies, with a pre increased net profit of 267 million yuan
Zhejiang Chint Electrics Co.Ltd(601877) it is announced that Zhejiang Zhengtai New Energy Development Co., Ltd., a wholly-owned subsidiary, plans to sign an equity transfer agreement with Guodian Ningbo Wind Power Development Co., Ltd. (hereinafter referred to as “Ningbo wind power”) to transfer 100% equity of Hangyang new energy and 81 industrial and commercial distributed photovoltaic power station project companies held by it to Ningbo wind power at a transfer price of 1036247900 yuan, The total installed capacity involved in this transaction is 512.05mw. According to preliminary calculation, this transaction is expected to increase the company’s net profit by about 267011800 yuan.
Shanghai Chlor-Alkali Chemical Co.Ltd(600618) it is proposed to purchase about 90000 tons / year of ethylene from SECCO
Shanghai Chlor-Alkali Chemical Co.Ltd(600618) announced that the company signed ethylene purchase and sales contracts with Shanghai Secco Petrochemical Co., Ltd. (hereinafter referred to as “SECCO”) and China Petroleum & Chemical Corporation(600028) Chemical Sales Co., Ltd. East China branch (hereinafter referred to as “Sinopec East China branch”), and the company purchased about 90000 tons / year of ethylene from SECCO. Sinopec East China branch is the agent of SECCO, Assist SECCO in dealing with ethylene sales orders, delivery and other matters. The contract period is 10 years.
Harbin Pharmaceutical Group Co.Ltd(600664) cefazolin sodium for injection passed the conformity evaluation of generic drugs
Harbin Pharmaceutical Group Co.Ltd(600664) announcement: the general pharmaceutical factory of Harbin Pharmaceutical Group, a branch of the company, received the notice of approval for drug supplementary application for two specifications of cefazolin sodium for injection issued by the State Drug Administration, and the drugs of the two specifications passed the consistency evaluation of generic drug quality and efficacy. Cefazolin is the first generation cephalosporin. The antibacterial spectrum is mainly Staphylococcus, Streptococcus, Streptococcus pneumoniae, Escherichia coli, Klebsiella pneumoniae, Proteus and other bacteria sensitive to cefazolin. At present, China has 135 production approvals of cefazolin sodium for injection in 3 specifications.
Shuangliang Eco-Energy Systems Co.Ltd(600481) won the bidding project of RMB 169 million
Shuangliang Eco-Energy Systems Co.Ltd(600481) announced that the company won the bid of Jiangsu energy Ulagai 2 × Bid section V of the first batch of auxiliary equipment procurement for the second auxiliary of 1000MW high-efficiency ultra supercritical coal-fired generating unit project: bidding project for indirect air cooling island of main engine and auxiliary equipment. The bid winning amount is 168.65 million yuan, accounting for 8.14% of the company’s audited operating revenue in 2020.
The subsidiary of Shanghai Fosun Pharmaceutical (Group) Co.Ltd(600196) plans to transfer 24% equity of Chongqing fuchuang for us $141 million
Shanghai Fosun Pharmaceutical (Group) Co.Ltd(600196) announced that Shanghai Fosun Pharmaceutical (Group) Co.Ltd(600196) industry, the holding subsidiary of the company, plans to make a cash contribution of US $141 million to acquire 23.9992% equity of Chongqing fuchuang (corresponding to the paid in registered capital of US $3.429 million). Chongqing fuchuang focuses on the research of small molecule targeted drugs for anti-tumor and metabolic diseases urgently needed in clinic, and has formed an innovative R & D system linked by Chongqing, Shanghai and San Francisco. After the completion of this transfer, Shanghai Fosun Pharmaceutical (Group) Co.Ltd(600196) industry and its holding subsidiaries Jiangsu Wanbang and Chongqing Medical Engineering Institute will jointly hold 100% equity of Chongqing fuchuang. Shanghai Fosun Pharmaceutical (Group) Co.Ltd(600196) will continue to promote the follow-up clinical, registration and commercialization of Chongqing fuchuang drugs under research with rich clinical registration capacity and industrialization resources.
Shanghai Electric Power Co.Ltd(600021) shareholders reduce 2.41% of the company’s shares
According to the announcement of Shanghai Electric Power Co.Ltd(600021) , the shareholder China Yangtze Power Co.Ltd(600900) reduced 63109500 shares of the company through centralized bidding and block trading on December 30, 2021, accounting for 2.41% of the total share capital of the company. After this equity change, China Yangtze Power Co.Ltd(600900) holds 197963950 shares of the company, accounting for 7.56% of the total share capital of the company.
Baiyin Nonferrous Group Co.Ltd(601212) : the shareholder Guoan group was applied for reorganization
Baiyin Nonferrous Group Co.Ltd(601212) announced that Guoan group, the shareholder holding 30.39% of the shares, received the notice served by Beijing No. 1 Intermediate People’s court, and the creditor Bank Of Communications Co.Ltd(601328) Heze branch applied to the court for reorganization of Guoan group. Gansu SASAC, Gansu Xinye Asset Management Co., Ltd. and Gansu Provincial Department of Finance jointly hold 33.48% of the shares of the company. The company has no actual controller, Guoan group is applied for reorganization by creditors, which has no impact on the company’s daily production and operation, and all production and operation activities of the company are normal.
Fujian Start Group Co.Ltd(600734) : completion of reorganization plan
Fujian Start Group Co.Ltd(600734) announced that the company received the civil ruling served by Fuzhou intermediate people’s Court on December 31, 2021, confirming that the reorganization plan of Shida group has been implemented. According to the reorganization plan and the company’s creditor’s rights and debts, through the company’s preliminary calculation, this reorganization will have a positive impact on the company’s net assets and net profit in 2021.
Sichuan Western Resources Holding Co.Ltd(600139) controlling shareholder and actual controller
Sichuan Western Resources Holding Co.Ltd(600139) it was announced that the 20.73% equity of the company held by Sichuan Hengkang, the former controlling shareholder of the company, was transferred to Beijing Meitong United Trading Co., Ltd. (hereinafter referred to as “Beijing Meitong”) by Hangzhou Gongshu District Court. After this judicial transfer, the controlling shareholder of the company changed from Guizhou huibaizhong to Beijing Meitong, and the actual controller changed from Zeng Tianping to Yang Xi.
(Shanghai Securities News · China Securities Network)
